# InvAscent

> InvAscent is a VC fund in Port Louis backing Medical and Health Care. See 16 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Port Louis, Mauritius
- Total investments: 16
- Last investment: Sep 2025
- Lead investor: 88%
- Last updated: Aug 2026
- Website: https://www.invascent.com/

InvAscent is a VC fund in Port Louis focused on Medical and Health Care. InvAscent is the investment advisor to EILSF (Fund I), India Life Sciences Fund II (ILSF-II) and India Life Sciences Fund III (ILSF-III). These funds provide private equity growth capital to companies in the Indian pharmaceutical, healthcare, animal health and medtech industries. Examples of funds usage include capacity expansion, introduction ofnew products, acquisitions, etc. The typical investment size is in the range of USD 10 - 40 million over the life of the investment for a significant minority stake.

## Contacts

5 contacts available for InvAscent. Shizune tracks 1 team members at InvAscent. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/invascent?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 6 | 38% |
| Health Care | 6 | 38% |
| Manufacturing | 6 | 38% |
| Pharmaceutical | 5 | 31% |
| Hospital | 3 | 19% |

21 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Private Equity | 13 | 81% |
| Series B | 1 | 6% |
| Series C | 1 | 6% |
| Secondary Market | 1 | 6% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| India | 13 | 81% |
| United States | 1 | 6% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| T.P. Devarajan | Managing Director | 4 | https://shizune.co/investors/profile/t-p-devarajan |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Apex Hospitals | Apex Hospitals offers cardio thoracic vascular surgery, cardiology, critical care, intensive care unit, dermatology, cosmetic, dietetics, nutrition, Ent, gastroenterology, gastrointestinal surgery, general surgery, laparoscopic, bariatric surgery, hematology, audiology, speech therapy, dental, and implant services. An online inquiry form isavailable on the company's website. |  | Secondary Market | Sep 29, 2025 |  |
| Apex Hospitals | Apex Hospitals offers cardio thoracic vascular surgery, cardiology, critical care, intensive care unit, dermatology, cosmetic, dietetics, nutrition, Ent, gastroenterology, gastrointestinal surgery, general surgery, laparoscopic, bariatric surgery, hematology, audiology, speech therapy, dental, and implant services. An online inquiry form isavailable on the company's website. | $29.9M | Private Equity | Sep 29, 2025 |  |
| SRV Hospital | SRV Hospital provides plastic surgery, psychiatry, pediatrics and neonatology, orthopedics, oncology, physiotherapy, neurology, nephrology, gynecology and obstetrics, general surgery-laparoscopy, gastroenterology, ent, dietetics, dermatology, pulmonary/respiratory medicine, and cardiology services. | $16.4M | Private Equity | Apr 19, 2025 |  |
| Maiva Pharma | Maiva Pharma is a manufacturer of liquid sterile formulations in small volume glass vials, ampoules, and large volume glass bottles. | $120M | Private Equity | May 02, 2024 |  |
| Fleming Laboratories | Fleming Laboratories provides API development and manufacturing facilities. Their services include research and development, manufacturing, infrastructure, and quality management. They respond to customer inquiries by phone and email. | $13.2M | Private Equity | Dec 19, 2023 |  |
| ABI Health | In addition to developing our own software to aid you in transferring images or keeping your records, we also act as consultants and provide valuable services to healthcare administrators and medical professionals. Regardless of the size of your practice or hospital, it's difficult and nearly impossible to do it alone. We make use of thelatest standards and practices to streamline your records and images, as well as develop unique software that further streamlines the acquisition and analysis of information. We also can help you integrate different sets of data, reducing load time and increasing the effectiveness of care. Take a look at some of what we do, and take a chance. | $10M | Private Equity | Dec 18, 2023 |  |
| Pregna International | Pregna International is a contraceptive device manufacturer that specializes in IUDs, hormonal IUDs, and tubal rings. | $15.9M | Private Equity | Jun 21, 2023 |  |
| General Diagnostics International | General Diagnostics International is a responsible laboratory that prioritizes the well-being of its patients. GD uses a combination of emotional devotion and innovation to reduce the cost of diagnostics to a fraction of what it is currently available for, allowing the masses to benefit. | $10.5M | Private Equity | Jun 06, 2023 |  |
| Sunways | Sunways is a pharmaceutical company, manufacturing and marketing a wide range of formulations in Ophthalmology and ENT. | $14.7M | Private Equity | Nov 25, 2022 |  |
| Accumax | Accumax is a producer of liquid handling products. | $67.2M | Private Equity | Jun 02, 2022 |  |

10 of 16 investments shown.

## Co-investors
- [Bessemer Venture Partners](https://shizune.co/investors/profile/bessemer-venture-partners) — VC Fund, 2 deals together
- [Creador](https://shizune.co/investors/profile/creador) — VC Fund, 2 deals together
- [FinSight Ventures](https://shizune.co/investors/profile/finsight-ventures) — VC Fund, 2 deals together
- [JIF Capital](https://shizune.co/investors/profile/jafco-asia) — VC Fund, 2 deals together
- [Quadria Capital](https://shizune.co/investors/profile/quadria-capital) — VC Fund, 2 deals together
- [Rebright Partners](https://shizune.co/investors/profile/rebright-partners) — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Foresight Group](https://shizune.co/investors/profile/foresight-group) — VC Fund
- [YFM Equity Partners](https://shizune.co/investors/profile/yfm-equity-partners) — VC Fund
- [Fondaction](https://shizune.co/investors/profile/fondaction) — VC Fund

## FAQ

### What does InvAscent invest in?

InvAscent invests primarily in Medical, Health Care and Manufacturing startups, most often at Private Equity and Series B stage. Most of the 16 investments tracked by Shizune back companies in India. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact InvAscent?

Public channels for InvAscent include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at InvAscent?

The team at InvAscent includes T.P. Devarajan (Managing Director). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co